China Yet To Approve Merck, GSK HPV Vaccines As Concerns Rise
This article was originally published in PharmAsia News
China’s drug authority has yet to approve HPV vaccines such as Gardasil, made by Merck, and Cervarix, by GlaxoSmithKline, already available in more than 100 nations and regions.
You may also be interested in...
Farah Ahmed, president and CEO of the Fragrance Creators Association, discusses the trade group’s expansion in recent years beyond immediate regulatory and legislative concerns to a platform for robust member collaboration in the name of positively impacting the world.
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.